# Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)

> **NCT05200871** · — · COMPLETED · sponsor: **Travere Therapeutics, Inc.** · enrollment: 487 (actual)

## Conditions studied

- Focal Segmental Glomerulosclerosis
- Immunoglobulin A Nephropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05200871
- **Lead sponsor:** Travere Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-05
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 487 (ACTUAL)
- **Last updated:** 2024-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05200871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05200871, "Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05200871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*